The burgeoning cannabis industry stands poised here for explosive growth if the federal government takes the crucial step of rescheduling cannabis. Currently, its classification as a Schedule I drug creates massive barriers to development, limits banking and investment options, and perpetuates harmful policies. Rescheduling would unlock a "Green Ru